Das J, et al. The use of autologous haematopoietic stem cell transplantation as a first line disease modifying therapy in patients with 'aggressive' multiple sclerosis. ECTRIMS 2018, abstract 230.
Sluis dure geneesmiddelen beperkt verdringing andere goede zorg
aug 2023